Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seo

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
RMD Open|March 29, 2023
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphismMarta Casal Moura, Zuoming Deng, Stephen R Brooks, et al.
The Journal of Rheumatology|December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel, Philip Seo, Peter Aries, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2018
Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitisSarah M Moran, Paul A Monach, Lina Zgaga, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
Plos One|October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitisRennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
Rheumatology (Oxford, England)|November 28, 2022
Ocular manifestations of ANCA-associated vasculitisMats L Junek, Lily Zhao, Stephanie Garner, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Clinical Immunology (Orlando, Fla.)|August 25, 2023
Mitochondrial-mediated inflammation and platelet activation in giant cell arteritisDespina Michailidou, Peter C Grayson, Payton Hermanson, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
RMD Open|March 29, 2023
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphismMarta Casal Moura, Zuoming Deng, Stephen R Brooks, et al.
The Journal of Rheumatology|December 7, 2005
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel, Philip Seo, Peter Aries, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2018
Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitisSarah M Moran, Paul A Monach, Lina Zgaga, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2014
Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvementDuvuru Geetha, Ulrich Specks, John H Stone, et al.
Arthritis Care & Research|October 4, 2016
Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated VasculitisZachary S Wallace, Eli M Miloslavsky, Matthew Cascino, et al.
Plos One|October 12, 2018
Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitisRennie L Rhee, Cecile T J Holweg, Kit Wong, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
Rheumatology (Oxford, England)|November 28, 2022
Ocular manifestations of ANCA-associated vasculitisMats L Junek, Lily Zhao, Stephanie Garner, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Clinical Immunology (Orlando, Fla.)|August 25, 2023
Mitochondrial-mediated inflammation and platelet activation in giant cell arteritisDespina Michailidou, Peter C Grayson, Payton Hermanson, et al.
Pageof 17